• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Riociguat(625115-55-1)
Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate
2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)
4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-
1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)
1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

Russians Threaten to Sue Over Vaccine Switch-Up — Reports

firstwordpharmaJune 22, 2021

Tag: COVID-19 , Vaccine , Sputnik V

Several Russian volunteers who claim they were given a less effective COVID-19 vaccine instead of the Sputnik V vaccine are considering pursuing legal action, as reported The Moscow Times on Monday.

Russians Threaten to Sue Over Vaccine Switch-Up — Reports

Seven patients said they were either misled into thinking they had received Sputnik V or met with a lack of Sputnik V doses at their vaccination sites, and were inoculated with EpiVacCorona.

Vektor Institute, which developed EpiVacCorona last year, said recently that nearly half of EpiVacCorona recipients lacked antibodies nine months after receiving the vaccine.

Russian health officials previously said that EpiVacCorona had 100% efficacy, according to the news source.

Previous:US approval for OTC use of Bayer’s Astepro

Next:Novartis’ radioligand therapy granted US Breakthrough Therapy Designation

Related News

Macrogen Consortium win tender for National Bio Big Data Project

PRNewswireDecember 23, 2024

Macrogen and Illumina Inc. (NASDAQ: ILMN) announced today that they are honoured to support the National Bio Big Data project by sequencing and analysing 145,952 Korean genomes.

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

PRNewswireDecember 23, 2024

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Russians Threaten to Sue Over Vaccine Switch-Up — Reports | Pharmasources.com

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Manulife Hong Kong today announced a new partnership with New Frontier Group, one of the leading healthcare service providers in Greater China, to introduce cashless services for eligible customers through New Frontier Group's subsidiary, Prosper Health.

You may like
More>>

Influenza Vaccine(Split Virion),Inactivated

Influenza Vaccine(Split Virion),Inactivated
Haemophilus Influenza Type B Conjugate Vaccine

Haemophilus Influenza Type B Conjugate Vaccine
Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production

Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production
Meningococcal Conjugate Vaccine (Group A+C), Freeze Dried

Meningococcal Conjugate Vaccine (Group A+C), Freeze Dried
Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)

Recombinant Hepatitis B Vaccine(Saccharomyces Cerevisiae)
OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral

OPV(Poliomyelitis(Live)Vaccine(Monkey Kidney Cell).Oral
Pet Vaccine Series

Pet Vaccine Series
2019-nCoV Vaccine(Vero Cells),Inactivated

2019-nCoV Vaccine(Vero Cells),Inactivated
Varicella Vaccine, Live

Varicella Vaccine, Live
DTaP-Hib combined Vaccine

DTaP-Hib combined Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service